doi: 10.2147/OTT.S544936.
eCollection 2025.
Crosstalk Between EGFR and Integrin Affects Invasion and Proliferation of Gastric Cancer Cell Line, SGC7901 [Retraction]
- PMID: 40524861
- PMCID: PMC12169025
- DOI: 10.2147/OTT.S544936
Item in Clipboard
Crosstalk Between EGFR and Integrin Affects Invasion and Proliferation of Gastric Cancer Cell Line, SGC7901 [Retraction]
Onco Targets Ther.
.
Abstract
[This retracts the article DOI: 10.2147/OTT.S35322.].
© 2025 Dove Medical Press.
Retraction of
-
Crosstalk between EGFR and integrin affects invasion and proliferation of gastric cancer cell line, SGC7901.Onco Targets Ther. 2012;5:271-7. doi: 10.2147/OTT.S35322. Epub 2012 Oct 23. Onco Targets Ther. 2012. Retraction in: Onco Targets Ther. 2025 Jun 10;18:733-734. doi: 10.2147/OTT.S544936. PMID: 23109808 Free PMC article. Retracted.
Similar articles
-
Crosstalk between EGFR and integrin affects invasion and proliferation of gastric cancer cell line, SGC7901.Onco Targets Ther. 2012;5:271-7. doi: 10.2147/OTT.S35322. Epub 2012 Oct 23. Onco Targets Ther. 2012. Retraction in: Onco Targets Ther. 2025 Jun 10;18:733-734. doi: 10.2147/OTT.S544936. PMID: 23109808 Free PMC article. Retracted.
-
A cross-talk between integrin β4 and epidermal growth factor receptor induces gefitinib chemoresistance to gastric cancer.Cancer Cell Int. 2018 Apr 2;18:50. doi: 10.1186/s12935-018-0548-5. eCollection 2018. Cancer Cell Int. 2018. PMID: 29618949 Free PMC article.
-
LncRNA FTX Promotes Proliferation and Invasion of Gastric Cancer via miR-144/ZFX Axis [Retraction].Onco Targets Ther. 2023 Nov 28;16:1013-1014. doi: 10.2147/OTT.S451969. eCollection 2023. Onco Targets Ther. 2023. PMID: 38047059 Free PMC article.
-
ERK1/2 signalling pathway is involved in CD147-mediated gastric cancer cell line SGC7901 proliferation and invasion.Exp Biol Med (Maywood). 2013 Aug 1;238(8):903-12. doi: 10.1177/1535370213493706. Epub 2013 Jul 4. Exp Biol Med (Maywood). 2013. PMID: 23828593
-
TRIM11 Promotes Proliferation, Migration, Invasion and EMT of Gastric Cancer by Activating β-Catenin Signaling [Retraction].Onco Targets Ther. 2024 Aug 30;17:731-732. doi: 10.2147/OTT.S493697. eCollection 2024. Onco Targets Ther. 2024. PMID: 39229604 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
